Comparable Diagnostic Value of 99mTc-FAPI-46 SPECT/CT and 18F-FDG PET/CT in Cholangiocarcinoma: A Case Report
We describe a 51-year-old man with cholangiocarcinoma of the common bile duct. Initially deemed nonmetastatic, he was a candidate for curative surgery and liver transplantation. However, during laparotomy, peritoneal seeding was discovered, necessitating omentectomy and lesion resection. Following chemotherapy, the patient underwent 18 F-FDG PET/CT for re-staging, revealing uptake in the primary tumor and a right iliac bone metastasis. Subsequently, FAPI-based scintigraphy using 99m Tc-FAPI-46 as a novel conventional imaging agent demonstrated comparable uptake in both lesions. This case highlights the diagnostic potential of 99m Tc-FAPI-46 SPECT/CT as an alternative to 18 F-FDG PET/CT and 68 Ga-FAPI in cholangiocarcinoma, particularly in resource-limited settings.
Authors
- Kamran Aryana (ORCID: https://orcid.org/0000-0003-2403-8903)
- Martha Ghahraman
- Atena Aghaee (ORCID: https://orcid.org/0000-0002-1351-3142)
- Nasrin Raeisi (ORCID: https://orcid.org/0009-0005-2087-2169)
- Amin Saber Tanha (ORCID: https://orcid.org/0009-0008-0290-0412)
Institutions
- Mashhad University of Medical Sciences (IR)
Publication Details
- Journal
- Clinical Nuclear Medicine
- Published
- 2025-05-09
- DOI
- https://doi.org/10.1097/rlu.0000000000005877
- Citations
- 1
- Primary Topic
- Peptidase Inhibition and Analysis
- Type
- article
- Field-Weighted Citation Impact
- 1.05